Illumina is a leading provider of sequencing and array-based technologies for genetic research and health applications. Learn about its mission, products, discoveries, and latest news on its website.
Careers - Illumina | Sequencing and array-based solutions...
At Illumina, Inc., we promise to treat your data with...
- About Us
About Us - Illumina | Sequencing and array-based solutions...
Illumina, Inc. is an American biotechnology company that develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. It serves more than 140 countries and offers products and services for sequencing, genotyping, gene expression, proteomics, and COVID-19 testing. Founded in 1998, it has a history of acquisitions and partnerships with other companies such as Solexa and Roche.
- 1998; 25 years ago
- US$4.58 billion (2022)
- 10,200 (Jan 2023)
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina | 419,744 followers on LinkedIn. Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic ...
People also ask
Is Illumina a biotechnology company?
What can Illumina do for You?
How many followers does Illumina have?
What is Illumina sequencing & array technology?
14 days ago • Morningstar. Insider Monkey. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing.